Cancer immunotherapy, which uses drugs that stimulate the body's immune cells to attack tumors, is a promising approach to ...

Adelaide researchers have identified a promising new biomarker and treatment target for ovarian cancer that could markedly ...

Northwestern Medicine scientists have discovered how a specific transcription factor promotes genetic reprogramming and ...

Researchers want to improve their understanding of the immune environment in ovarian cancer in hopes of making immunotherapy an option for these patients. Researchers now report on key characteristics ...

Cancer is a malignant disease referring to the uncontrollable proliferation of mutated cells. Millions of individuals are affected by cancer each year in the United States alone. Unfortunately, ...

Ovarian cancer is the fifth biggest cause of cancer death in women, and part of its frustrating stubbornness to treat and high level of recurrence may be down to some surprisingly cellular cooperation ...

Prior research on the potential role of cytokines found that IL-6 signaling can reprogram and alter T-cell immune responses ...

Trials-in-progress poster of ongoing pivotal Phase 3 trial of DNA-mediated immunotherapy accepted at both IGCS and ESMO Congress ...

Understanding how the ovarian reserve develops could enable more sophisticated ovarian disease models, aiding treatment development. Utilizing cutting-edge single-cell sequencing and spatial ...